FDA Approves Groundbreaking Drug for Treating Multiple Food Allergies
TL;DR Summary
The FDA has approved Xolair, also known as omalizumab, as a new drug to reduce severe allergic reactions to certain foods in adults and children over the age of 1, potentially redefining the treatment of food allergies. While it won't eliminate food allergies, it aims to reduce the risk of harmful allergic reactions from accidental exposure. Developed by Genentech, Xolair has shown promise in helping patients tolerate foods they are allergic to over time, with the most common side effects being reactions at the injection site and fever. This approval marks a significant advancement in managing food allergies for the estimated 20 million Americans affected.
- 'Long-awaited' drug to treat food allergies, including nuts, gets FDA approval — could 'redefine' treatment New York Post
- FDA approves a drug to treat severe food allergies, including milk, eggs and nuts NPR
- FDA approves medication used to treat asthma for use in people with multiple food allergies CNN
- Asthma medication appears to reduce some allergic reactions TODAY
- FDA: People with severe food allergies can get treatment with Xolair USA TODAY
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
80%
524 → 105 words
Want the full story? Read the original article
Read on New York Post